S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)

Theravance Biopharma (TBPH) Insider Trading & Ownership

$10.47
+0.09 (+0.87%)
(As of 11/29/2023 ET)
Compare
Today's Range
$10.39
▼
$10.60
50-Day Range
$8.38
▼
$10.50
52-Week Range
$8.25
▼
$12.03
Volume
316,887 shs
Average Volume
478,160 shs
Market Capitalization
$521.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Theravance Biopharma (NASDAQ:TBPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$918,131.32
Get TBPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theravance Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TBPH Insider Buying and Selling by Quarter


Theravance Biopharma Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2023Rhonda FarnumSVPSell1,378$10.29$14,179.62  
11/14/2023Richard A GrahamSVPSell2,482$10.22$25,366.04  
10/16/2023Richard A GrahamSVPSell2,482$9.03$22,412.46  
9/14/2023Richard A GrahamSVPSell2,482$9.89$24,546.98  
8/22/2023Rhonda FarnumSVPSell1,807$9.47$17,112.29  
8/11/2023Richard A GrahamSVPSell2,322$9.99$23,196.78  
7/14/2023Richard A GrahamSVPSell2,322$9.84$22,848.48  
6/14/2023Richard A GrahamSVPSell2,322$10.69$24,822.18  
6/8/2023Rhonda FarnumSVPSell1,790$11.13$19,922.70  
5/15/2023Richard A GrahamSVPSell2,322$11.26$26,145.72  
4/14/2023Richard A GrahamSVPSell2,323$11.88$27,597.24  
3/14/2023Richard A GrahamSVPSell2,323$10.32$23,973.36  
3/9/2023Rhonda FarnumSVPSell4,000$10.20$40,800.00  
3/6/2023Richard A GrahamSVPSell2,323$10.05$23,346.15  
12/14/2022Rick E WinninghamCEOSell50,000$11.19$559,500.00  
12/1/2022Richard A GrahamSVPSell2,084$10.73$22,361.32  
(Data available from 1/1/2013 forward)












TBPH Insider Trading Activity - Frequently Asked Questions

Who is on Theravance Biopharma's Insider Roster?

The list of insiders at Theravance Biopharma includes Philip D Worboys, Rhonda Farnum, Richard A Graham, and Rick E Winningham. Learn more on insiders at TBPH.

What percentage of Theravance Biopharma stock is owned by insiders?

5.30% of Theravance Biopharma stock is owned by insiders. Learn more on TBPH's insider holdings.

Which Theravance Biopharma insiders have been selling company stock?

The following insiders have sold TBPH shares in the last 24 months: Rhonda Farnum ($125,604.90), Richard A Graham ($446,859.91), and Rick E Winningham ($559,500.00).

How much insider selling is happening at Theravance Biopharma?

Insiders have sold a total of 108,191 Theravance Biopharma shares in the last 24 months for a total of $1,131,964.81 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:TBPH) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -